We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $15.1B
1-Year Est. Return 27.93%
This Fund
S&P 500
This Quarter Est. Return
-0.71%
1 Year Est. Return
+27.93%
3 Year Est. Return
+64.69%
5 Year Est. Return
+64.07%
10 Year Est. Return
AUM
$3.54B
AUM Growth
+$107M
Cap. Flow
+$179M
Cap. Flow %
5.05%
Top 10 Hldgs %
20.31%
Holding
4,474
New
404
Increased
1,575
Reduced
1,479
Closed
707
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIP icon
276
iShares TIPS Bond ETF
TIP
$15B
$2.03M 0.06%
18,386
-14,574
-44% -$1.61M
MOAT icon
277
VanEck Morningstar Wide Moat ETF
MOAT
$12.5B
$2.03M 0.06%
20,949
+18,181
+657% +$1.88M
FLOT icon
278
iShares Floating Rate Bond ETF
FLOT
$10.6B
$2.01M 0.06%
39,512
+26,358
+200% +$1.34M
DHR icon
279
Danaher
DHR
$152B
$2.01M 0.06%
10,594
+664
+7% +$141K
TXN icon
280
Texas Instruments
TXN
$236B
$2M 0.06%
10,298
+338
+3% +$68.4K
LMT icon
281
Lockheed Martin
LMT
$130B
$1.98M 0.06%
3,268
-1,118
-25% -$689K
CSHI icon
282
NEOS Enhanced Income 1-3 Month T-Bill ETF
CSHI
$1.66B
$1.97M 0.06%
39,581
-62,559
-61% -$3.11M
INTC icon
283
Intel
INTC
$473B
$1.93M 0.05%
43,669
+15,850
+57% +$727K
BLK icon
284
Blackrock
BLK
$180B
$1.91M 0.05%
1,981
+401
+25% +$422K
SCHX icon
285
Schwab US Large- Cap ETF
SCHX
$74.3B
$1.89M 0.05%
73,853
+43,458
+143% +$1.17M
MRSH
286
Marsh
MRSH
$91.9B
$1.89M 0.05%
10,901
+6,090
+127% +$1.09M
BNY
287
Bank of New York Mellon
BNY
$110B
$1.89M 0.05%
15,689
+62
+0.4% +$7.37K
TMO icon
288
Thermo Fisher Scientific
TMO
$230B
$1.86M 0.05%
3,782
-2,577
-41% -$1.4M
AIRR icon
289
First Trust RBA American Industrial Renaissance ETF
AIRR
$9.61B
$1.86M 0.05%
16,761
-594
-3% -$67.2K
AVEM icon
290
Avantis Emerging Markets Equity ETF
AVEM
$28B
$1.85M 0.05%
22,735
-212,240
-90% -$17.6M
QYLD icon
291
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.34B
$1.84M 0.05%
107,442
+30,527
+40% +$537K
BOTZ icon
292
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.4B
$1.84M 0.05%
55,289
+21,366
+63% +$789K
AMGN icon
293
Amgen
AMGN
$234B
$1.84M 0.05%
5,229
-481
-8% -$171K
CRM icon
294
Salesforce
CRM
$211B
$1.83M 0.05%
9,791
-2,265
-19% -$469K
JPST icon
295
JPMorgan Ultra-Short Income ETF
JPST
$40.8B
$1.81M 0.05%
35,817
+12,107
+51% +$613K
FDS icon
296
Factset
FDS
$11B
$1.81M 0.05%
8,330
+8,101
+3,538% +$1.89M
TROW icon
297
T. Rowe Price
TROW
$23.7B
$1.8M 0.05%
19,913
+17,480
+718% +$1.69M
ZBH icon
298
Zimmer Biomet
ZBH
$19.2B
$1.79M 0.05%
19,826
+19,287
+3,578% +$1.77M
ISRG icon
299
Intuitive Surgical
ISRG
$132B
$1.79M 0.05%
3,893
-910
-19% -$460K
KLAC icon
300
KLA
KLAC
$229B
$1.77M 0.05%
12,040
-4,600
-28% -$673K

Similar funds

Arax Advisory Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Arax Advisory Partners held 4,474 positions worth $3.54B, up 3.1% from $3.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Arax Advisory Partners deployed $179M of net new capital in Q1 2026, opening 404 new positions and adding to 1,575 existing holdings. Its largest new stake was FT Vest US Equity Moderate Buffer ETF August: 789,886 shares worth $30.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, up from 68% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $32.9M trimmed.

  • Arax Advisory Partners's largest Q1 2026 buy was FT Vest US Equity Moderate Buffer ETF August: 789,886 shares worth $30.6M.
  • Arax Advisory Partners added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $59M increase.
  • Arax Advisory Partners's biggest Q1 2026 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $32.9M.
  • Arax Advisory Partners fully exited Willis Towers Watson in Q1 2026, selling an estimated $746K.
  • Arax Advisory Partners's ten largest holdings make up 20% of its $3.54B portfolio in Q1 2026.
  • Arax Advisory Partners opened 404 new positions and closed 707 in Q1 2026.
  • Arax Advisory Partners's portfolio value rose 3.1% quarter-over-quarter to $3.54B.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.